The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for elexacaftor/tezacaftor/ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
elexacaftor/tezacaftor/ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Granules
Indication
For the treatment of cystic fibrosis (CF)
Therapeutic area
Respiratory